AI will be the dominant disrupting technology in upcoming two years: Survey
The pharmaceutical industry is heavily investing in artificial intelligence (AI) to enhance efficiency and deliver pipeline candidates.
AI
AI and Big Data expected to garner maximum investment over next two years
In the past few years, the pharmaceutical industry recorded increasing investment in several emerging technologies...
Big data and AI are likely to lead emerging technology investments: Survey
With digital transformation gradually picking up pace, the pharmaceutical industry has witnessed an increase in...
Is the pharma sector seeing the beginnings of an AI investment boom?
AI deals, jobs and patents have been booming in the last few years. But is...
Strong leadership dominates as key factor for digital transformation across geographies
The pharmaceutical industry believes that the top management of a company plays a crucial role...
Baidu founder and CEO says now is the time for AI-powered SBDD drug discovery
Li announced funding and partnerships for his new firm BioMap, which he says will develop a “global immunity map” and discover new drugs and treatments using AI data handling.
Changing the face of pharma sales with AI
Using artificial intelligence (AI), pharmaceutical sales platform ODAIA is attempting to change the way pharma sales reps approach their work. Pharmaceutical Technology sat down with the company to learn more about how its platform works...
Valence Discovery: transforming AI-enabled drug design with ‘few-shot learning’
The use of artificial intelligence to support drug discovery and design efforts is a rapidly expanding field, with new players looking to streamline AI’s role in drug discovery and translation. One such player is Montreal-headquartered...
University team uses AI to decode asbestos-linked cancer
Researchers at the University of Leicester have used artificial intelligence (AI) to gain new insights into mesothelioma, a cancer caused by breathing asbestos particles that typically occurs in the linings of the lungs or abdomen.
Collaboration not competition: is big pharma and big tech a recipe for success?
Big tech’s growing interest in the healthcare sector has largely been seen to put it on a collision course with big pharma. However, there are early signs of a culture of collaboration emerging between big...
Komodo Health secures $220m in Series E funding round
Health analytics start-up Komodo Health has closed a $220m Series E funding round, giving the company a valuation of $3.3bn.
